Olmesartan and Drug-Induced Enteropathy

نویسنده

  • Michele B. Kaufman
چکیده

Dr. Tran is Assistant Clinical Professor at St. John’s University and Clinical Pharmacy Manager at New York–Presbyterian Hospital/ Columbia University Medical Center in New York City. Hanlin Li is a fi nal-year doctor of pharmacy candidate at St. John’s University College of Pharmacy and Health Sciences, in Jamaica, New York. She is also a pharmacy intern at New York–Presbyterian Hospital–Weill Cornell Medical Center. Dr. Michele B. Kaufman, editor of the Pharmacovigilance Forum column, is a freelance medical writer and Certifi ed Geriatric Pharmacist living in New York City; a Pharmacist at the New York– Presbyterian Lower Manhattan Hospital, Pharmacy Department; and Adjunct Assistant Professor at Touro College of Pharmacy in New York City. Olmesartan and Drug-Induced Enteropathy

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Olmesartan-Induced Sprue Like Enteropathy

Chronic diarrhoea is a common clinical problem in gastroenterology practice and often it is difficult to diagnose the cause. Villous atrophy is not specific and the rarer possibility of drug-induced enteritis should always be considered. Olmesartan has recently been described as a cause of drug-induced enteropathy characterized by chronic diarrhoea and varying degrees of duodenal mucosa atrophy...

متن کامل

Seronegative Intestinal Villous Atrophy: A Diagnostic Challenge

Celiac disease is the most important cause of intestinal villous atrophy. Seronegative intestinal villous atrophy, including those that are nonresponsive to a gluten-free diet, is a diagnostic challenge. In these cases, before establishing the diagnosis of seronegative celiac disease, alternative etiologies of atrophic enteropathy should be considered. Recently, a new clinical entity responsibl...

متن کامل

Rare Case of Olmesartan Induced Enteropathy

HANDA R, RAHMAN A, VIVEK K. A Rare Case of Olmesartan-Induced Enteropathy. Spartan Med. Res. J. Vol. 2, No. 2, pp. 29-37, 2017. CONTEXT: Olmesartan (brand name Benicar) is an antihypertensive drug clinicians commonly use to treat high blood pressure. Olmesartan induced enteropathy (OSE) is a rare entity that authors first identified in 2012. The etiological basis of OSE remains unclear, althoug...

متن کامل

[Olmesartan-associated enteropathy: attention to an emerging iatrogenic phenomenon].

Olmesartan is an angiotensin II type 1 receptor blocker commonly used in the treatment of hypertension. Several cases of sprue-like enteropathy associated with the use of this drug have been described which, even with important signs and limitations for the patient, present a full recovery after discontinuing the use of olmesartan. The case of a 64 year-old patient is presented, diagnosed with ...

متن کامل

A Case of Severe Sprue-Like Enteropathy Associated With Valsartan

Olmesartan sprue-like enteropathy is an adverse drug reaction that mimics the appearance of celiac disease and is related to the use of olmesartan. We present the case of a 71-year-old female with severe enteropathy attributed to celiac disease for 5 years that improved only after valsartan cessation. This is the first case associating valsartan with sprue-like enteropathy.

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2014